6月24日电,安进减肥药Maritide在第二阶段第一部分临床研究中表现出平均减重20%的效果。
Group 1 - The core point of the article is that Amgen's weight loss drug Maritide has shown an average weight reduction of 20% in the first part of its Phase 2 clinical trial [1]
Group 1 - The core point of the article is that Amgen's weight loss drug Maritide has shown an average weight reduction of 20% in the first part of its Phase 2 clinical trial [1]